Clinical Trial Update: A Study to Assess the Safety, Tolerability, and Pharmacokinetics of Multiple Ascending Doses of the ABT-333 Tablet [Phase 1]

View source ↗

Summary

A Phase 1 study assessing safety, tolerability, and pharmacokinetics of multiple ascending doses of the ABT-333 tablet in Hepatitis C patients has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hepatitis C

Drugs mentioned

• ABT-333 (ABT-333)

Snippet

Sponsor: Abbott | Conditions: HCV Infection | Phase 1 | Status: COMPLETED